跳至主要内容
临床试验/NCT05472350
NCT05472350Unknown不适用

Efficacy and Safety of Perioperative Use of Breztri Aerosphere to Relieve Cough After Lobectomy: A Prospective, Randomized, Placebo-controlled Single Center Trial

Jianxing He0 个研究点目标入组 128 人开始时间: 2022年8月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
发起方
入组人数
128
主要终点
Incidence of significant cough two weeks after surgery

研究概览

简要总结

Cough after lobectomy is common. The prevention and treatment of cough after lobectomy is not standardized. Breztri Aerosphere is often used to relieve cough. Therefore, we conduct a single center placebo-controlled study to evaluate the efficacy and safety of perioperative use of Breztri Aerosphere in relieving cough after lobectomy.

详细描述

This study is a single-center, prospective, randomized, controlled clinical trial to understand the efficacy and safety of perioperative use of Breztri in relieving cough after lobectomy. This study plans to include 128 subjects from the Department of Thoracic Surgery of the First Affiliated Hospital of Guangzhou Medical University. Participants will be randomly divided into according Breztri group and placebo group to the ratio of 1:1. Participants in Placebo group will receive 0.9% normal saline for 3 days before operation and 14 days after operation (n=64). Participants in Breztri group will receive Breztri for 3 days before operation and 14 days after operation (n=64). All patients will undergo screening and baseline visits. After sugery, they will be followed up for 2 months.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects voluntarily participate in this research and abide by the research regulations, understand and comply with and cooperate with the corresponding inspections, comply with the follow-up plan, and voluntarily sign the written informed consent.
  • Outpatients, 18 years old ≤ age ≤ 70 years old, preoperative examination of cardiopulmonary function can tolerate surgery.
  • Patients planning to undergo lobectomy.
  • No obvious cough before surgery.

排除标准

  • Participated in other interventional clinical trials 90 days before enrollment
  • Pregnant and lactating women (budigrafo is not recommended during pregnancy and lactation)
  • Patients with obvious cough before surgery (which affects the evaluation of drug effect)
  • History of alcohol or narcotic drug abuse, or a history of mental illness, confrontational personality, bad motivation, paranoia, or other emotional or intellectual problems that may affect the informed validity of participation in this study
  • Preoperative respiratory infection, allergic rhinitis, bronchial asthma, chronic obstructive pulmonary disease, postnasal drip syndrome, oral ACEI drugs, CVA, EB, obvious acid reflux, heartburn, etc.
  • Patients with severe cardiac insufficiency or heart-related diseases before surgery
  • Diabetes before surgery
  • Severe liver and kidney damage before surgery
  • ACEI/ARB used within 1 month 9) Use of drugs that may cause cough or suppress cough within 1 month 9) Preoperative narrow-angle glaucoma, benign prostatic hyperplasia, or bladder neck obstruction 10) Patients who are using beta2 agonists or acetylcholine receptor antagonists or inhaled glucocorticoids 11) Tumor recurrence 13) Patients with severe infection or obvious pleural effusion found on postoperative chest X-ray

研究组 & 干预措施

Breztri Aerosphere Group

Experimental

Participants will receive Breztri Aerosphere twice a day from 3 days before surgery to 14 days after surgery

干预措施: Breztri Aerosphere (Drug)

Placebo Group

Placebo Comparator

Participants will receive 0.9% normal saline twice a day from 3 days before surgery to 14 days after surgery

干预措施: Placebo (Other)

结局指标

主要结局

Incidence of significant cough two weeks after surgery

时间窗: 12 weeks

Cough Evaluation Test (CET) is an easy way to assess the cough condition. A Visual Analogue Scale (VAS) is a cough rating scale. Significnant cough means VAS more than 3 or any item of CET score more than 2.

次要结局

  • The total and sub-scores of the Cough Evaluation Test (CET) score of each day after surgery(12 weeks)
  • Incidence of significant cough 1 month after surgery(12 weeks)
  • LCQ-MC at 1 month after surgery(12 weeks)
  • the number of days the cough lasts(12 weeks)
  • Cough start time(12 weeks)
  • Inflammatory factor levels in venous blood before and after surgery(12 weeks)
  • length of postoperative hospital stay(12 weeks)
  • Incidence of serious postoperative pneumonia(12 weeks)

研究者

发起方
Jianxing He
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Jianxing He

Director

The First Affiliated Hospital of Guangzhou Medical University

相似试验

Efficacy and Safety of Perioperative Use of Breztri... | 临床试验